Position in FATE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$655,210
-$319,092 QoQ
Shares Held
242,671
-70.1% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. FATE ranks #287 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in FATE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $655,210 | 242,671 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $974,302 | 811,920 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $718,015 | 732,670 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,026,224 | 814,465 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $945,670 | 844,350 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $628,027 | 794,973 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,329,102 | 805,518 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,853,058 | 815,160 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $2,416,289 | 736,674 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,255,820 | 716,052 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,650,121 | 708,589 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,646,208 | 1,248,212 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,961,713 | 1,252,461 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,476,151 | 785,290 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,703,068 | 763,436 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,204,155 | 767,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,226,973 | 775,907 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,234,085 | 779,832 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,516,378 | 812,107 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $48,802,738 | 823,397 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $76,781,374 | 884,680 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $72,730,957 | 882,122 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $81,233,949 | 893,368 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $36,676,710 | 917,606 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $30,148,023 | 878,695 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $17,761,779 | 799,720 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||